CDKN1A and lymphoma: Moreover, other studies have reported the modulation of p21cip1/waf1 expression after HDAC inhibition in lymphoma [116], leukemia [117], hepatocellular carcinoma [118], and breast cancer [119]; however, histone marks were not investigated.